Raffaele Manni Selected Research

Disorders of Excessive Somnolence (Hypersomnia)

11/2022	Insomnia in primary care: a survey conducted on Italian patients older than 50 years-results from the "Sonno e Salute" study.
1/2017	Treating sleep apnea in Parkinson's disease with C-PAP: feasibility concerns and effects on cognition and alertness.
3/2004	Dopamine agonists and sleepiness in PD: review of the literature and personal findings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raffaele Manni Research Topics

Disease

8	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2023 - 07/2008
4	REM Sleep Behavior Disorder 01/2022 - 09/2014
3	Disorders of Excessive Somnolence (Hypersomnia) 11/2022 - 03/2004
3	Dementia (Dementias) 01/2022 - 04/2010
2	Parasomnias (Parasomnia) 09/2022 - 06/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2019
2	Parkinsonian Disorders (Parkinsonism) 01/2022 - 05/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 11/2019
2	Hallucinations (Hallucination) 11/2020 - 06/2018
2	Epilepsy (Aura) 09/2015 - 08/2010
1	Mood Disorders (Mood Disorder) 01/2021
1	Sleep Wake Disorders 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Autism Spectrum Disorder 01/2021
1	Temporal Lobe Epilepsy 01/2020
1	Drug Resistant Epilepsy 01/2020
1	Enuresis 06/2018
1	Sleep Paralysis 06/2018
1	Nervous System Diseases (Neurological Disorders) 06/2018
1	Idiopathic Generalized Epilepsy 01/2016
1	Juvenile Myoclonic Epilepsy 01/2016
1	Partial Epilepsies (Epilepsy, Partial) 09/2015
1	Lung Diseases (Lung Disease) 03/2014
1	Parkinson Disease (Parkinson's Disease) 03/2004
1	Sleepiness 03/2004
1	Fistula 02/2002
1	Arteriovenous Fistula 02/2002
1	False Aneurysm (Pseudoaneurysm) 02/2002

Drug/Important Bio-Agent (IBA)

7	MelatoninIBA 01/2021 - 01/2011
4	Indicators and Reagents (Reagents)IBA 01/2023 - 12/2015
3	Clonazepam (Rivotril)FDA LinkGeneric 06/2020 - 05/2015
2	mesoglycanIBA 12/2023 - 01/2021
2	Hypnotics and Sedatives (Sedatives)IBA 01/2021 - 07/2008
2	Dopamine Agonists (Dopamine Agonist)IBA 11/2020 - 03/2004
2	Levodopa (L Dopa)FDA LinkGeneric 11/2020 - 03/2004
1	Coffee FDA Link 01/2022
1	SynucleinsIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 06/2018
1	Imipramine (Janimine)FDA LinkGeneric 06/2018
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 06/2018
1	CannabinoidsIBA 06/2018
1	Antidepressive Agents (Antidepressants)IBA 06/2018
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 06/2018
1	Immunoglobulin E (IgE)IBA 01/2016
1	AntibodiesIBA 09/2014
1	AntigensIBA 09/2014
1	GlucocorticoidsIBA 03/2014
1	MagnesiumIBA 01/2011
1	ZincIBA 01/2011
1	Rivastigmine (Exelon)FDA LinkGeneric 04/2010
1	amsonic acid (DAS)IBA 03/2004

Therapy/Procedure

2	Therapeutics 09/2022 - 01/2020
2	Continuous Positive Airway Pressure 01/2017 - 08/2010
1	Phototherapy (Light Therapy) 01/2021
1	Duration of Therapy 11/2020
1	Electrodes (Electrode) 01/2020
1	Long-Term Care 01/2011
1	Laparoscopic Cholecystectomy 02/2002
1	Surgical Instruments (Clip) 02/2002
1	Nephrectomy 02/2002